Annual Accounts Payable
$2.43 M
+$848.00 K+53.47%
December 31, 2023
Summary
- As of February 8, 2025, TARA annual accounts payable is $2.43 million, with the most recent change of +$848.00 thousand (+53.47%) on December 31, 2023.
- During the last 3 years, TARA annual accounts payable has risen by +$1.52 million (+166.30%).
- TARA annual accounts payable is now at all-time high.
Performance
TARA Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$2.29 M
+$910.00 K+65.70%
September 30, 2024
Summary
- As of February 8, 2025, TARA quarterly accounts payable is $2.29 million, with the most recent change of +$910.00 thousand (+65.70%) on September 30, 2024.
- Over the past year, TARA quarterly accounts payable has dropped by -$209.00 thousand (-8.35%).
- TARA quarterly accounts payable is now -43.76% below its all-time high of $4.08 million, reached on March 31, 2023.
Performance
TARA Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
TARA Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +53.5% | -8.3% |
| 3 y3 years | +166.3% | -8.3% |
| 5 y5 years | +451.9% | -8.3% |
TARA Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +155.1% | -43.8% | +485.5% |
| 5 y | 5-year | at high | +239.9% | -43.8% | +485.5% |
| alltime | all time | at high | +451.9% | -43.8% | +1461.2% |
Protara Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.29 M(+65.7%) |
| Jun 2024 | - | $1.39 M(+42.5%) |
| Mar 2024 | - | $972.00 K(-60.1%) |
| Dec 2023 | $2.43 M(+53.5%) | $2.43 M(-2.8%) |
| Sep 2023 | - | $2.50 M(+35.2%) |
| Jun 2023 | - | $1.85 M(-54.6%) |
| Mar 2023 | - | $4.08 M(+157.3%) |
| Dec 2022 | $1.59 M(+66.2%) | $1.59 M(+247.8%) |
| Sep 2022 | - | $456.00 K(+16.3%) |
| Jun 2022 | - | $392.00 K(-27.5%) |
| Mar 2022 | - | $541.00 K(-43.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $954.00 K(+4.4%) | $954.00 K(+2.8%) |
| Sep 2021 | - | $928.00 K(-33.9%) |
| Jun 2021 | - | $1.40 M(-24.3%) |
| Mar 2021 | - | $1.85 M(+102.7%) |
| Dec 2020 | $914.00 K(+27.7%) | $914.00 K(-52.2%) |
| Sep 2020 | - | $1.91 M(+109.0%) |
| Jun 2020 | - | $915.20 K(-65.5%) |
| Mar 2020 | - | $2.65 M(+270.1%) |
| Dec 2019 | $716.00 K(+62.4%) | $716.00 K(+387.1%) |
| Sep 2019 | - | $147.00 K |
| Dec 2018 | $441.00 K | - |
FAQ
- What is Protara Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Protara Therapeutics?
- What is Protara Therapeutics annual accounts payable year-on-year change?
- What is Protara Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Protara Therapeutics?
- What is Protara Therapeutics quarterly accounts payable year-on-year change?
What is Protara Therapeutics annual accounts payable?
The current annual accounts payable of TARA is $2.43 M
What is the all time high annual accounts payable for Protara Therapeutics?
Protara Therapeutics all-time high annual accounts payable is $2.43 M
What is Protara Therapeutics annual accounts payable year-on-year change?
Over the past year, TARA annual accounts payable has changed by +$848.00 K (+53.47%)
What is Protara Therapeutics quarterly accounts payable?
The current quarterly accounts payable of TARA is $2.29 M
What is the all time high quarterly accounts payable for Protara Therapeutics?
Protara Therapeutics all-time high quarterly accounts payable is $4.08 M
What is Protara Therapeutics quarterly accounts payable year-on-year change?
Over the past year, TARA quarterly accounts payable has changed by -$209.00 K (-8.35%)